Outcomes
PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing
PreventionGeneticsis the perfect complement to Exact Sciences’ advanced cancer diagnostics portfolio and supports its entrance into hereditary cancer testing (HCT).
Outcomes
OmniSeq Received a Strategic Investment from HITACHI April 12, 2018
Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq.
Outcomes
MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018
Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics.
Outcomes
OmniSeq Received a Strategic Investment from LabCorp August 21, 2017
Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq Inc.
Outcomes
Access Regional Laboratory Business acquired by LabCorp June, 2017
Crosstree Capital Partners acted as exclusive financial advisor to Access.
Outcomes
Converge acquired by Quest Diagnostics October 7, 2013
Crosstree Capital Partners served as exclusive financial advisor to Water Street and ConVerge.